From the Editor-In-Chief
The U.S. health care system must adapt to the needs of cancer survivors.
by William G. Nelson, MD, PhD
A Matter of Age | Alternatives to Opioids | Treating Head and Neck Skin Cancers | In Women, Lung Cancer Rates Are Rising Worldwide | Breaking Down Breakthrough Cancer Therapies | The Devastating Impact of Muscle Wasting | What’s Next?
Your Cancer Guide
Deciding when and what to worry about can help with gaining control over fear.
by Hester Hill Schnipper
Caregiving with Confidence
Healthy sleep habits should be an important part of self-care for caregivers.
by Aimee Swartz
Let your voice be heard in support of robust, sustained and predictable federal funding increases.
by George D. Demetri, MD
Breast cancer survivor Bob Riter forges connections among people affected by all types of cancer.
by Marci A. Landsmann
New tools are being integrated into the research process to ease patients’ access to clinical trials and improve their experience.
by Bradley Jones
Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies.
by Kate Yandell
Cancer and its treatment can hinder sexual intimacy, but help is available. Talking about the problem is the first step.
by Cameron Walker
Carb Connection | Make Your Move
Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain.
Experts offer advice on accompanying a friend to a doctor’s appointment, responding to a no evidence of disease diagnosis, and sharing the results of genetic testing.
The End of Treatment Bells fundraiser helps patients mark milestones.
by Sophy Ziss
Readers share snapshots of their lives today.
My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.
by Allison Rosen
Researchers are investigating why certain patients have an exceptional response to a particular drug.
Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults.
An analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.
by Anna Azvolinsky
A session highlighted immunotherapy combinations and a liquid biopsy-based strategy for predicting progression-free survival.
The FDA has expanded the use of the PARP-targeted therapeutic olaparib to include the treatment of certain patients with metastatic prostate cancer.
While melanoma is rarer than other forms of skin cancer, it is more aggressive and more likely to spread to other organs.
Handle With Care
donate to the AACR